Edward G. Galante - 10 Aug 2026 Form 4 Insider Report for Celanese Corp (CE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Aug 2026, 16:06:06 UTC
Prior SEC filing
22 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christine Dryden, Attorney-in-Fact for Edward G. Galante

Key filing fact

Edward G. Galante filed Form 4 for Celanese Corp (CE) on 12 Aug 2026.

Key facts

  • This page summarizes Edward G. Galante's Form 4 filing for Celanese Corp (CE).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 Aug 2026, 16:06.

Change

  • Previous filing in this sequence was filed on 22 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001199009 Primary reporting owner

GALANTE EDWARD G

Relationship
Director
Address
C/O CELANESE CORPORATION, 222 W. LAS COLINAS BLVD., SUITE 900N, IRVING
Signature
/s/ Christine Dryden, Attorney-in-Fact for Edward G. Galante
Signature date
12 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CE transaction

Common Stock

Award

Transaction value
Shares
+1,930
Change %
+7.4%
Price
$0.000000*
Shares after
27,983
Date
10 Aug 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CE transaction Derivative

Phantom Stock

Award

Transaction value
Shares
+5
Change %
+0.07%
Price
$44.46*
Shares after
6,815
Date
10 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Annual grant of fully vested restricted stock units pursuant to the Amended and Restated Company's 2018 Global Incentive Plan. The restricted stock units were granted to compensate the reporting person for his prior service as Chair of the Board.

Footnote F2

Each share of phantom stock represents the right to receive one share of Common Stock.

Footnote F3

The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .